Programming cell behavior with synthetic protease-activated receptors
Matthew RavaliniD, Nicholas A. KalogriopoulosiD, Rocco LatorreiD, Gabriele KockelkoreniD, Reika TeiiD, Martina ChiecaiD, Francesco De LoguiD, Nigel W. BunnettiD, Alice Y. TingiD
Abstract
Extracellular proteases are important signaling molecules in coagulation, inflammation, cell migration, and pain. Dysregulation of extracellular protease activity is common in diseases that perturb these critical functions. Engineering cells to sense and respond programmatically to protease activity has applications in biosensing, cell-based screening for protease activity, and therapeutics. Here we report synthetic protease-activated receptors (SynPARs) based on engineered, auto-inhibited G protein-coupled receptors (GPCRs). Relief of autoinhibition by proteolysis enables receptor activation by an exogenous or tethered agonist to generate transgene expression, real-time fluorescence, or endogenous G-protein signaling. We demonstrate SynPAR modularity with diverse secreted proteases, establish a cell-based SynPAR library selection to optimize protease recognition sequences, and control neuronal activity in response to protease activity. Finally, we use SynPARs in the dorsal root ganglion of mice to counteract hyperalgesia produced by trypsin activity, rewiring neurons to produce an analgesic response to a pain-inducing stimulus. Our study establishes SynPAR as a versatile and modular platform for recording, sensing, and responding to pericellular proteolysis. This fills a critical gap in protease-sensing tools and lays the groundwork for protease-activated genetic and cell-based medicines.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The PAR2 signal peptide prevents premature receptor cleavage and activation
- The cellular basis of protease activated receptor type 2 (PAR2) evoked mechanical and affective pain
Shayne N. Hassler, Moeno Kume, … Theodore John Price·JCI InsightPeer-reviewed·Apr 30, 2020
- Nanomedicines targeting signaling of protease-activated receptor 2 in organelles provide sustained analgesia
Shavonne L. Teng, Rocco Latorre, … Nigel W. Bunnett·Proceedings of the National Academy of SciencesPeer-reviewed·Oct 7, 2025
- A role for protease activated receptor type 3 (PAR3) in nociception demonstrated through development of a novel peptide agonist
Juliet M. Mwirigi, Moeno Kume, … Theodore John Price·Journal of PainPeer-reviewed·Jan 12, 2021
- ProNotch converts extracellular protease activity into programmable transcriptional outputs
Jeremy C. Tran, Christopher J. Kuffner, … John T. Ngo·bioRxiv·Jun 3, 2026
- A modular live-cell biosensor for extracellular protease activity
Beatrice Ramm, Maia Weatherly, Jared E. Toettcher·bioRxiv·Jun 22, 2026